Impact BioMedical Inc.
IBO
$0.45
-$0.0225-4.76%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 66.89% | 361.72% | 65.29% | -26.86% | -9.50% |
| Depreciation & Amortization | 1.07% | -0.36% | 0.36% | -0.36% | 0.00% |
| Other Operating Expenses | 3,733.33% | 11.88% | 650.00% | 200.00% | -57.14% |
| Total Operating Expenses | 31.00% | -23.18% | 4.55% | -37.90% | -3.99% |
| Operating Income | -31.00% | 23.18% | -4.55% | 37.90% | 3.99% |
| Income Before Tax | -28.06% | -2,049.09% | 460.32% | 21.14% | -17.55% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.06% | -2,051.70% | 460.32% | 21.14% | -17.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -69.44% | -3.85% | -60.00% | -126.32% | -81.25% |
| Net Income | -31.70% | -2,094.98% | 465.49% | 19.33% | -46.42% |
| EBIT | -31.00% | 23.18% | -4.55% | 37.90% | 3.99% |
| EBITDA | -31.21% | 23.29% | -4.46% | 37.87% | 4.00% |
| EPS Basic | -9.15% | -5,521.24% | 2,337.58% | -469.87% | -934.41% |
| Normalized Basic EPS | -11.05% | -258.53% | 2,363.73% | -475.26% | -1,125.00% |
| EPS Diluted | -10.00% | -4,868.99% | 400.00% | -350.00% | -900.00% |
| Normalized Diluted EPS | -11.05% | -258.53% | 461.76% | -475.26% | -1,125.00% |
| Average Basic Shares Outstanding | 20.63% | -60.99% | -83.68% | -85.82% | -85.81% |
| Average Diluted Shares Outstanding | 20.63% | -60.99% | 2.13% | -85.82% | -85.81% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |